TY - JOUR
T1 - Proteomic analysis at the bedside
T2 - early detection of cancer.
AU - Petricoin, Emanuel F.
AU - Liotta, Lance A.
PY - 2002/12
Y1 - 2002/12
N2 - Proteomic technologies promise to accelerate rapidly a new era in molecular medicine, especially in the detection and discovery of disease-related biomarkers. These technologies have no bigger impact than in the field of human cancer research. Beyond lifestyle-associated prevention strategies, early detection of cancer has the most profound impact on the ultimate course of the disease: the earlier the cancer is detected, the better the prognosis. Today, new proteomic technologies are being used to discover new diagnostic and prognostic biomarkers for the early detection and treatment of cancer that will have important implications at the bedside.
AB - Proteomic technologies promise to accelerate rapidly a new era in molecular medicine, especially in the detection and discovery of disease-related biomarkers. These technologies have no bigger impact than in the field of human cancer research. Beyond lifestyle-associated prevention strategies, early detection of cancer has the most profound impact on the ultimate course of the disease: the earlier the cancer is detected, the better the prognosis. Today, new proteomic technologies are being used to discover new diagnostic and prognostic biomarkers for the early detection and treatment of cancer that will have important implications at the bedside.
UR - http://www.scopus.com/inward/record.url?scp=0037945662&partnerID=8YFLogxK
U2 - 10.1016/s1471-1931(02)00204-5
DO - 10.1016/s1471-1931(02)00204-5
M3 - Review article
C2 - 12570157
AN - SCOPUS:0037945662
SN - 0167-7799
VL - 20
SP - S30-34
JO - Trends in biotechnology
JF - Trends in biotechnology
IS - 12 Suppl
ER -